(300908, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300909, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300910, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300911, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300912, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300913, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300914, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300915, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300916, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300917, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300918, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300919, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300920, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300921, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300922, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300923, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300924, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300925, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300926, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300927, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300928, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300929, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300930, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300931, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300932, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300933, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300934, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300935, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300936, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300937, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300938, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300939, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300940, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300941, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300942, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300943, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300944, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300945, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300946, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300947, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300948, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300949, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300950, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300951, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300952, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300953, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300954, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300955, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300956, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300957, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300958, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300959, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300960, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300961, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300962, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300963, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300964, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300965, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300966, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300967, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300968, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300969, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300970, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300971, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300972, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300973, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300974, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300975, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300976, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300977, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300978, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300979, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300980, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300981, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300982, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300983, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300984, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300985, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300986, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300987, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300988, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300989, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300990, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300991, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300992, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300993, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300994, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300995, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300996, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300997, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(300998, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(300999, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301000, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301001, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301002, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301003, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301004, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301005, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301006, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301007, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301008, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301009, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301010, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301011, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301012, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301013, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301014, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301015, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301016, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301017, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301018, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301019, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301020, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301021, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301022, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301023, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301024, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301025, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301026, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301027, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301028, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301029, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301030, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301031, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301032, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301033, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301034, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301035, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301036, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301037, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301038, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301039, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301040, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301041, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301042, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301043, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301044, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301045, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301046, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301047, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301048, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301049, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301050, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301051, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301052, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301053, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301054, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301055, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301056, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301057, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301058, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301059, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301060, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301061, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301062, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301063, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301064, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301065, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301066, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301067, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301068, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301069, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301070, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301071, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301072, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301073, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301074, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301075, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301076, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301077, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301078, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301079, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301080, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301081, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301082, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301083, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301084, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301085, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301086, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301087, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301088, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301089, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301090, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301091, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301092, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301093, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301094, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301095, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301096, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301097, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301098, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301099, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301100, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301101, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301102, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301103, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301104, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301105, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301106, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301107, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301108, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301109, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301110, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301111, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301112, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301113, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301114, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301115, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301116, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301117, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301118, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301119, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301120, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301121, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301122, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301123, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301124, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301125, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301126, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301127, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301128, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301129, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301130, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301131, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301132, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301133, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301134, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301135, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301136, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301137, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301138, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301139, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301140, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301141, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301142, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301143, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301144, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301145, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301146, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301147, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301148, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301149, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301150, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301151, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301152, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301153, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301154, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301155, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301156, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301157, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301158, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301159, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301160, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301161, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301162, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301163, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301164, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301165, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301166, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301167, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301168, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301169, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301170, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301171, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301172, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301173, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301174, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301175, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301176, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301177, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301178, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301179, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301180, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301181, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301182, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301183, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301184, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301185, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301186, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301187, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301188, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301189, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301190, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301191, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301192, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301193, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301194, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301195, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301196, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301197, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301198, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301199, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301200, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301201, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301202, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301203, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301204, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301205, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301206, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301207, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301208, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301209, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301210, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301211, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301212, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301213, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301214, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301215, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301216, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301217, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301218, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301219, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301220, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301221, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301222, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301223, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301224, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301225, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301226, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301227, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301228, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301229, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301230, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301231, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301232, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301233, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301234, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301235, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301236, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301237, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301238, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301239, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301240, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301241, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301242, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301243, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301244, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301245, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301246, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301247, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301248, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301249, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301250, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301251, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301252, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301253, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301254, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301255, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301256, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301257, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301258, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301259, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301260, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301261, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301262, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301263, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301264, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301265, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301266, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301267, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301268, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301269, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301270, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301271, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301272, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301273, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301274, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301275, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301276, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301277, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301278, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301279, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301280, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301281, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301282, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301283, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301284, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301285, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301286, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301287, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301288, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301289, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301290, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301291, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301292, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301293, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301294, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301295, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301296, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301297, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301298, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301299, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301300, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301301, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301302, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301303, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301304, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301305, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301306, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301307, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301308, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301309, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301310, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301311, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301312, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301313, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301314, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301315, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301316, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301317, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301318, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301319, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301320, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301321, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301322, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301323, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301324, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301325, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301326, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301327, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301328, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301329, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301330, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301331, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301332, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301333, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301334, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301335, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301336, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301337, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301338, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301339, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301340, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301341, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301342, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301343, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301344, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301345, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301346, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301347, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301348, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301349, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301350, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301351, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301352, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301353, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301354, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301355, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301356, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301357, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301358, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301359, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301360, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301361, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301362, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301363, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301364, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301365, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301366, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301367, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301368, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301369, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301370, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301371, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301372, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301373, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301374, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301375, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301376, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301377, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301378, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301379, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301380, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301381, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301382, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301383, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301384, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301385, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301386, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301387, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301388, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301389, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301390, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301391, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301392, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301393, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301394, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301395, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301396, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301397, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301398, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301399, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301400, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301401, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301402, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301403, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301404, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301405, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301406, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301407, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301408, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301409, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301410, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301411, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301412, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301413, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301414, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301415, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301416, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301417, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301418, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301419, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301420, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301421, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301422, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301423, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301424, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301425, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301426, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301427, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301428, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301429, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301430, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301431, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301432, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301433, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301434, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301435, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301436, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301437, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301438, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301439, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301440, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301441, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301442, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301443, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301444, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301445, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301446, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301447, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301448, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301449, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301450, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301451, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301452, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301453, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301454, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301455, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301456, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301457, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301458, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301459, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301460, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301461, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301462, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301463, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301464, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301465, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301466, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301467, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301468, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301469, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301470, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301471, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301472, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301473, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301474, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301475, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301476, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301477, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301478, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301479, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301480, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301481, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301482, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301483, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301484, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301485, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301486, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301487, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301488, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301489, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301490, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301491, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301492, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301493, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301494, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301495, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301496, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301497, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301498, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301499, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301500, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301501, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301502, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301503, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301504, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301505, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301506, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(301507, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301508, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301509, 'HP:4000020', 'Anti-BP180 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(301510, 'HP:0012162', 'Common carotid artery dissection', 'MP:0006133', 'calcified artery', 0.42857142857142855, 8.259895016664046, 1.8814768154675023, 'UPHENO:0086797', 'abnormal artery morphology'),
(301511, 'HP:0012162', 'Common carotid artery dissection', 'MP:0006134', 'artery occlusion', 0.4090909090909091, 8.259895016664046, 1.838218692474474, 'UPHENO:0086797', 'abnormal artery morphology'),
(301512, 'HP:0012162', 'Common carotid artery dissection', 'MP:0000265', 'blood vessel atresia', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(301513, 'HP:0012162', 'Common carotid artery dissection', 'MP:0011655', 'abnormal systemic artery morphology', 0.41025641025641024, 9.101997348968142, 1.9323956009448564, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(301514, 'HP:0012162', 'Common carotid artery dissection', 'MP:0012562', 'blood vessel degeneration', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(301515, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301516, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006072', 'abnormal retina apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301517, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0002090', 'abnormal vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301518, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001851', 'eye inflammation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301519, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0014157', 'alacrima', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301520, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005258', 'ocular hypertension', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301521, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006224', 'oculomotor apraxia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301522, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0014132', 'abnormal tear film physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301523, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006157', 'palsy of the eye', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301524, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006148', 'binocular blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301525, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006190', 'retina ischemia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301526, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301527, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012031', 'abnormal b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301528, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020439', 'absent b-wave', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301529, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020861', 'abnormal corneal wound healing', 0.46153846153846156, 8.795504987450572, 2.014811117787919, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301530, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301531, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012154', 'decreased b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301532, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006150', 'double vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301533, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020960', 'increased c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301534, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012039', 'abnormal b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301535, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005251', 'blepharitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301536, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006251', 'eyelid apraxia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301537, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005253', 'abnormal eye physiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301538, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013479', 'scleritis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301539, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006145', 'legal blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301540, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006147', 'monocular blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301541, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020860', 'abnormal cornea physiology', 0.5142857142857142, 8.795504987450572, 2.126829227976374, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301542, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020974', 'abnormal FO-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301543, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005257', 'abnormal intraocular pressure', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301544, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0008144', 'nyctalopia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301545, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006203', 'eye hemorrhage', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301546, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012040', 'abnormal c-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301547, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0003101', 'high myopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301548, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0003011', 'delayed dark adaptation', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301549, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301550, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020958', 'abnormal c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301551, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012148', 'decreased a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301552, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020959', 'decreased c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301553, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012152', 'decreased a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301554, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0010749', 'absent visual evoked potential', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301555, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012035', 'abnormal b-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301556, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301557, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020977', 'decreased FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301558, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012036', 'abnormal a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301559, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006194', 'keratoconjunctivitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301560, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006252', 'lateral rectus palsy', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301561, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012037', 'abnormal b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301562, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006152', 'tunnel vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301563, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0030933', 'hyphema', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301564, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301565, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012145', 'increased a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301566, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020962', 'increased c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301567, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301568, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013145', 'eye discharge', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301569, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012151', 'increased a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301570, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020979', 'decreased FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301571, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0002001', 'blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301572, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012033', 'abnormal ERG implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301573, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013480', 'cyclitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301574, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0002638', 'abnormal pupillary reflex', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301575, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013478', 'corneal limbitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301576, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005551', 'abnormal eye electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301577, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013466', 'keratoconjunctivitis sicca', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301578, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012147', 'increased a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301579, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020220', 'decreased tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301580, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012038', 'abnormal a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301581, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0004022', 'abnormal cone electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301582, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0031497', 'increased visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301583, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005515', 'uveitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301584, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006201', 'vitreous body inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301585, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012149', 'decreased b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301586, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301587, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301588, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0005260', 'ocular hypotension', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301589, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001337', 'dry eyes', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301590, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301591, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012034', 'abnormal a-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301592, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0003100', 'myopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301593, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020218', 'abnormal tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301594, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001389', 'abnormal eye movement', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301595, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012143', 'decreased a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301596, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006229', 'iris inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301597, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0003096', 'increased corneal light-scattering', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301598, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0004021', 'abnormal rod electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301599, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013468', 'chromodacryorrhea', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301600, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0008145', 'hemeralopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301601, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012146', 'increased b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301602, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020980', 'increased FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301603, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301604, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0011275', 'abnormal behavioral response to light', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301605, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020963', 'decreased c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301606, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020961', 'abnormal c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301607, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006156', 'abnormal visual pursuit', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301608, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001999', 'photosensitivity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301609, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001852', 'conjunctivitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301610, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301611, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301612, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012150', 'increased b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301613, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0003665', 'endophthalmitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301614, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0011832', 'abnormal visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301615, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012030', 'abnormal a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301616, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020219', 'increased tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301617, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006149', 'decreased visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301618, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0001848', 'choroid inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301619, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0006153', 'hypermetropia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301620, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012153', 'increased b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301621, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012032', 'abnormal ERG latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301622, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0020976', 'increased FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301623, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0010748', 'abnormal visual evoked potential', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301624, 'HP:0030462', 'Abnormal amplitude of flash visual evoked potentials', 'MP:0012144', 'decreased b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(301625, 'HP:0031736', 'Involutional entropion', 'MP:0001302', 'eyelids open at birth', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301626, 'HP:0031736', 'Involutional entropion', 'MP:0005176', 'eyelids fail to open', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301627, 'HP:0031736', 'Involutional entropion', 'MP:0006168', 'epicanthus inversus', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301628, 'HP:0031736', 'Involutional entropion', 'MP:0002697', 'abnormal eye size', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301629, 'HP:0031736', 'Involutional entropion', 'MP:0006249', 'phthisis bulbi', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301630, 'HP:0031736', 'Involutional entropion', 'MP:0030041', 'abnormal forehead size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(301631, 'HP:0031736', 'Involutional entropion', 'MP:0002092', 'abnormal eye morphology', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301632, 'HP:0031736', 'Involutional entropion', 'MP:0030166', 'increased inner canthal distance', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301633, 'HP:0031736', 'Involutional entropion', 'MP:0031289', 'unilateral microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301634, 'HP:0031736', 'Involutional entropion', 'MP:0031290', 'bilateral microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301635, 'HP:0031736', 'Involutional entropion', 'MP:0009274', 'buphthalmos', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301636, 'HP:0031736', 'Involutional entropion', 'MP:0006248', 'lagophthalmos', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301637, 'HP:0031736', 'Involutional entropion', 'MP:0006163', 'ankyloblepharon filiform', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301638, 'HP:0031736', 'Involutional entropion', 'MP:0030167', 'decreased inner canthal distance', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301639, 'HP:0031736', 'Involutional entropion', 'MP:0030163', 'abnormal canthus morphology', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301640, 'HP:0031736', 'Involutional entropion', 'MP:0006225', 'ocular rupture', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301641, 'HP:0031736', 'Involutional entropion', 'MP:0013745', 'abnormal eyelid margin morphology', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301642, 'HP:0031736', 'Involutional entropion', 'MP:0001343', 'pronounced eyelids', 0.425531914893617, 10.404207209241001, 2.104120295206122, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301643, 'HP:0031736', 'Involutional entropion', 'MP:0006162', 'thick eyelids', 0.4230769230769231, 10.404207209241001, 2.0980419378888553, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301644, 'HP:0031736', 'Involutional entropion', 'MP:0006166', 'eyelid retraction', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301645, 'HP:0031736', 'Involutional entropion', 'MP:0004874', 'abnormal timing of postnatal eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301646, 'HP:0031736', 'Involutional entropion', 'MP:0013396', 'eyelid hyperplasia', 0.44, 10.404207209241001, 2.139591356326259, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301647, 'HP:0031736', 'Involutional entropion', 'MP:0013451', 'nasolacrimal duct obstruction', 0.4074074074074074, 9.175301480945878, 1.9334129896464194, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(301648, 'HP:0031736', 'Involutional entropion', 'MP:0001296', 'macrophthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301649, 'HP:0031736', 'Involutional entropion', 'MP:0001344', 'blepharoptosis', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301650, 'HP:0031736', 'Involutional entropion', 'MP:0009263', 'abnormal eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301651, 'HP:0031736', 'Involutional entropion', 'MP:0001297', 'microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301652, 'HP:0031736', 'Involutional entropion', 'MP:0006164', 'ectropion', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301653, 'HP:0031736', 'Involutional entropion', 'MP:0003153', 'early eyelid opening', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301654, 'HP:0031736', 'Involutional entropion', 'MP:0003671', 'abnormal eyelid aperture', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301655, 'HP:0031736', 'Involutional entropion', 'MP:0005287', 'narrow eye opening', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301656, 'HP:0031736', 'Involutional entropion', 'MP:0006165', 'entropion', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301657, 'HP:0031736', 'Involutional entropion', 'MP:0001299', 'abnormal eye distance/ position', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301658, 'HP:0031736', 'Involutional entropion', 'MP:0013146', 'eye lesions', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301659, 'HP:0031736', 'Involutional entropion', 'MP:0010081', 'posterior microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301660, 'HP:0031736', 'Involutional entropion', 'MP:0006209', 'calcified intraocular region', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301661, 'HP:0031736', 'Involutional entropion', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(301662, 'HP:0031736', 'Involutional entropion', 'MP:0001286', 'abnormal eye development', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301663, 'HP:0031736', 'Involutional entropion', 'MP:0030063', 'abnormal face size', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(301664, 'HP:0031736', 'Involutional entropion', 'MP:0009651', 'abnormal eyelid development', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301665, 'HP:0031736', 'Involutional entropion', 'MP:0009859', 'eye opacity', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(301666, 'HP:0031736', 'Involutional entropion', 'MP:0001340', 'abnormal eyelid morphology', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301667, 'HP:0031736', 'Involutional entropion', 'MP:0001290', 'delayed eyelid opening', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301668, 'HP:0031736', 'Involutional entropion', 'MP:0013395', 'eyelid hypoplasia', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(301669, 'HP:0002139', 'Arrhinencephaly', 'MP:0000913', 'abnormal brain development', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301670, 'HP:0002139', 'Arrhinencephaly', 'MP:0020532', 'abnormal pons size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301671, 'HP:0002139', 'Arrhinencephaly', 'MP:0002741', 'small olfactory bulb', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301672, 'HP:0002139', 'Arrhinencephaly', 'MP:0002152', 'abnormal brain morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(301673, 'HP:0002139', 'Arrhinencephaly', 'MP:0012137', 'abnormal forebrain size', 0.5263157894736842, 9.371930806217245, 2.220944655133705, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301674, 'HP:0002139', 'Arrhinencephaly', 'MP:0012775', 'abnormal brain weight', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(301675, 'HP:0002139', 'Arrhinencephaly', 'MP:0012139', 'increased forebrain size', 0.45454545454545453, 9.371930806217245, 2.0639691248370373, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301676, 'HP:0002139', 'Arrhinencephaly', 'MP:0012463', 'increased optic tract size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301677, 'HP:0002139', 'Arrhinencephaly', 'MP:0002654', 'spongiform encephalopathy', 0.4166666666666667, 5.028460092616607, 1.4474777045802536, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(301678, 'HP:0002139', 'Arrhinencephaly', 'MP:0006102', 'decreased tegmentum size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301679, 'HP:0002139', 'Arrhinencephaly', 'MP:0020569', 'abnormal premotor cortex size', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301680, 'HP:0002139', 'Arrhinencephaly', 'MP:0010058', 'enlarged olfactory bulb', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301681, 'HP:0002139', 'Arrhinencephaly', 'MP:0012263', 'decreased hindbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301682, 'HP:0002139', 'Arrhinencephaly', 'MP:0005238', 'increased brain size', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(301683, 'HP:0002139', 'Arrhinencephaly', 'MP:0020140', 'increased brain external capsule size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301684, 'HP:0002139', 'Arrhinencephaly', 'MP:0013935', 'basal brain tissue herniation', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(301685, 'HP:0002139', 'Arrhinencephaly', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301686, 'HP:0002139', 'Arrhinencephaly', 'MP:0020525', 'abnormal thalamus size', 0.4634146341463415, 7.13344151829186, 1.8181697366867442, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301687, 'HP:0002139', 'Arrhinencephaly', 'MP:0020557', 'abnormal ventromedial hypothalamic nucleus size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301688, 'HP:0002139', 'Arrhinencephaly', 'MP:0020530', 'disorganized thalamus', 0.4634146341463415, 7.13344151829186, 1.8181697366867442, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301689, 'HP:0002139', 'Arrhinencephaly', 'MP:0000774', 'decreased brain size', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(301690, 'HP:0002139', 'Arrhinencephaly', 'MP:0012140', 'forebrain hyperplasia', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301691, 'HP:0002139', 'Arrhinencephaly', 'MP:0002809', 'increased spinal cord size', 0.42105263157894735, 5.838687225017717, 1.567926854499307, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(301692, 'HP:0002139', 'Arrhinencephaly', 'MP:0012506', 'brain atrophy', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(301693, 'HP:0002139', 'Arrhinencephaly', 'MP:0020526', 'enlarged thalamus', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301694, 'HP:0002139', 'Arrhinencephaly', 'MP:0008026', 'abnormal brain white matter morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301695, 'HP:0002139', 'Arrhinencephaly', 'MP:0000784', 'forebrain hypoplasia', 0.40816326530612246, 9.371930806217245, 1.9558317617036163, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301696, 'HP:0002139', 'Arrhinencephaly', 'MP:0000785', 'telencephalon hypoplasia', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301697, 'HP:0002139', 'Arrhinencephaly', 'MP:0012468', 'decreased striatum size', 0.41304347826086957, 7.13344151829186, 1.7165143450276692, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301698, 'HP:0002139', 'Arrhinencephaly', 'MP:0021002', 'brain lesion', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(301699, 'HP:0002139', 'Arrhinencephaly', 'MP:0011380', 'enlarged brain ventricles', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301700, 'HP:0002139', 'Arrhinencephaly', 'MP:0006254', 'thin cerebral cortex', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301701, 'HP:0002139', 'Arrhinencephaly', 'MP:0030014', 'calcified brain', 0.4857142857142857, 6.213399309526074, 1.7372210013363565, 'UPHENO:0076805', 'abnormal brain morphology'),
(301702, 'HP:0002139', 'Arrhinencephaly', 'MP:0013229', 'abnormal brain ventricle size', 0.46153846153846156, 6.72807461644252, 1.762176270294449, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301703, 'HP:0002139', 'Arrhinencephaly', 'MP:0000789', 'thickened cerebral cortex', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301704, 'HP:0002139', 'Arrhinencephaly', 'MP:0012464', 'decreased optic tract size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301705, 'HP:0002139', 'Arrhinencephaly', 'MP:0020066', 'abnormal neocortex size', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301706, 'HP:0002139', 'Arrhinencephaly', 'MP:0012712', 'spinal cord degeneration', 0.43243243243243246, 5.838687225017717, 1.588973794285664, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(301707, 'HP:0002139', 'Arrhinencephaly', 'MP:0000771', 'abnormal brain size', 0.4857142857142857, 6.213399309526074, 1.7372210013363565, 'UPHENO:0076805', 'abnormal brain morphology'),
(301708, 'HP:0002139', 'Arrhinencephaly', 'MP:0000956', 'decreased spinal cord size', 0.42105263157894735, 5.838687225017717, 1.567926854499307, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(301709, 'HP:0002139', 'Arrhinencephaly', 'MP:0012508', 'forebrain atrophy', 0.40816326530612246, 9.371930806217245, 1.9558317617036163, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301710, 'HP:0002139', 'Arrhinencephaly', 'MP:0000783', 'abnormal forebrain morphology', 0.45454545454545453, 7.13344151829186, 1.800686929314863, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301711, 'HP:0002139', 'Arrhinencephaly', 'MP:0008025', 'brain vacuoles', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301712, 'HP:0002139', 'Arrhinencephaly', 'MP:0012265', 'increased hindbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301713, 'HP:0002139', 'Arrhinencephaly', 'MP:0000841', 'abnormal hindbrain morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301714, 'HP:0002139', 'Arrhinencephaly', 'MP:0009022', 'abnormal brain meninges morphology', 0.4166666666666667, 6.213399309526074, 1.6090109940485793, 'UPHENO:0076805', 'abnormal brain morphology'),
(301715, 'HP:0002139', 'Arrhinencephaly', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301716, 'HP:0002139', 'Arrhinencephaly', 'MP:0012481', 'increased habenula size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301717, 'HP:0002139', 'Arrhinencephaly', 'MP:0020553', 'abnormal stria medullaris size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301718, 'HP:0002139', 'Arrhinencephaly', 'MP:0006291', 'aprosencephaly', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301719, 'HP:0002139', 'Arrhinencephaly', 'MP:0013227', 'small brain ventricles', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301720, 'HP:0002139', 'Arrhinencephaly', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.4411764705882353, 7.13344151829186, 1.7740086110804494, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301721, 'HP:0002139', 'Arrhinencephaly', 'MP:0000791', 'delaminated cerebral cortex', 0.4523809523809524, 7.13344151829186, 1.7963944633066253, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301722, 'HP:0002139', 'Arrhinencephaly', 'MP:0012560', 'increased forebrain volume', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301723, 'HP:0002139', 'Arrhinencephaly', 'MP:0000830', 'abnormal diencephalon morphology', 0.4166666666666667, 7.13344151829186, 1.724026478708571, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301724, 'HP:0002139', 'Arrhinencephaly', 'MP:0002882', 'abnormal neuron morphology', 0.40540540540540543, 5.028460092616607, 1.4277832126804608, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(301725, 'HP:0002139', 'Arrhinencephaly', 'MP:0004101', 'abnormal brain interneuron morphology', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(301726, 'HP:0002139', 'Arrhinencephaly', 'MP:0008914', 'enlarged cerebellum', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301727, 'HP:0002139', 'Arrhinencephaly', 'MP:0005277', 'abnormal brainstem morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301728, 'HP:0002139', 'Arrhinencephaly', 'MP:0000852', 'small cerebellum', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301729, 'HP:0002139', 'Arrhinencephaly', 'MP:0012138', 'decreased forebrain size', 0.45454545454545453, 9.371930806217245, 2.0639691248370373, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301730, 'HP:0002139', 'Arrhinencephaly', 'MP:0000787', 'abnormal telencephalon morphology', 0.42857142857142855, 7.13344151829186, 1.7484819764942052, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301731, 'HP:0002139', 'Arrhinencephaly', 'MP:0012088', 'abnormal midbrain size', 0.43902439024390244, 6.72807461644252, 1.7186590284286045, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301732, 'HP:0002139', 'Arrhinencephaly', 'MP:0020541', 'abnormal substantia nigra size', 0.41304347826086957, 7.13344151829186, 1.7165143450276692, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301733, 'HP:0002139', 'Arrhinencephaly', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(301734, 'HP:0002139', 'Arrhinencephaly', 'MP:0003232', 'abnormal forebrain development', 0.4166666666666667, 7.13344151829186, 1.724026478708571, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301735, 'HP:0002139', 'Arrhinencephaly', 'MP:0009024', 'abnormal brain arachnoid mater morphology', 0.40540540540540543, 6.213399309526074, 1.5871186679086364, 'UPHENO:0076805', 'abnormal brain morphology'),
(301736, 'HP:0002139', 'Arrhinencephaly', 'MP:0012092', 'diencephalon hypoplasia', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301737, 'HP:0002139', 'Arrhinencephaly', 'MP:0012262', 'abnormal hindbrain size', 0.45, 6.72807461644252, 1.7400096486511603, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301738, 'HP:0002139', 'Arrhinencephaly', 'MP:0002229', 'neurodegeneration', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(301739, 'HP:0002139', 'Arrhinencephaly', 'MP:0012559', 'decreased forebrain volume', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(301740, 'HP:0002139', 'Arrhinencephaly', 'MP:0006007', 'abnormal basal ganglion morphology', 0.42857142857142855, 7.13344151829186, 1.7484819764942052, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301741, 'HP:0002139', 'Arrhinencephaly', 'MP:0000839', 'hypothalamus hyperplasia', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301742, 'HP:0002139', 'Arrhinencephaly', 'MP:0011854', 'cerebral edema', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(301743, 'HP:0002139', 'Arrhinencephaly', 'MP:0012681', 'collapsed brain ventricles', 0.42857142857142855, 6.72807461644252, 1.698075543049819, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(301744, 'HP:0002139', 'Arrhinencephaly', 'MP:0012467', 'increased striatum size', 0.41304347826086957, 7.13344151829186, 1.7165143450276692, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301745, 'HP:0002139', 'Arrhinencephaly', 'MP:0020141', 'decreased brain external capsule size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301746, 'HP:0002139', 'Arrhinencephaly', 'MP:0000831', 'diencephalon hyperplasia', 0.4523809523809524, 7.13344151829186, 1.7963944633066253, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301747, 'HP:0002139', 'Arrhinencephaly', 'MP:0004166', 'abnormal limbic system morphology', 0.42857142857142855, 7.13344151829186, 1.7484819764942052, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301748, 'HP:0002139', 'Arrhinencephaly', 'MP:0012482', 'decreased habenula size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301749, 'HP:0002139', 'Arrhinencephaly', 'MP:0020527', 'small thalamus', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(301750, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301751, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012332', 'decreased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301752, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031243', 'abnormal circulating CSF3 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301753, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301754, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0001570', 'abnormal circulating enzyme level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301755, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012324', 'abnormal circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301756, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031107', 'abnormal circulating myoglobin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301757, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031082', 'decreased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301758, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0002941', 'increased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301759, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301760, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008820', 'abnormal blood uric acid level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301761, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012615', 'decreased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301762, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301763, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012223', 'increased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301764, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012614', 'abnormal circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301765, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301766, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020984', 'decreased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301767, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008588', 'abnormal circulating interleukin level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301768, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301769, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012666', 'increased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301770, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301771, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012328', 'decreased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301772, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020985', 'increased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301773, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0013257', 'decreased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301774, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012221', 'abnormal circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301775, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020216', 'decreased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301776, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005416', 'abnormal circulating protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301777, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031079', 'increased circulating troponin I level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301778, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031083', 'increased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301779, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301780, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301781, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012618', 'decreased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301782, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031077', 'increased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301783, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012622', 'increased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301784, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020255', 'absent circulating factor XII protein', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301785, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012621', 'decreased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301786, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301787, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010091', 'decreased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301788, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005667', 'abnormal circulating leptin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301789, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301790, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301791, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0013256', 'increased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301792, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020983', 'abnormal circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301793, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0009699', 'hyperchylomicronemia', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301794, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0030745', 'increased circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301795, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008548', 'abnormal circulating interferon level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301796, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301797, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0002695', 'abnormal circulating glucagon level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301798, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011891', 'decreased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301799, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011894', 'decreased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301800, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011893', 'increased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301801, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301802, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301803, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011912', 'abnormal circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301804, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005567', 'decreased circulating total protein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301805, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301806, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301807, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301808, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301809, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011887', 'decreased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301810, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031075', 'abnormal circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301811, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301812, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301813, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011892', 'abnormal circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301814, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011890', 'increased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301815, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0030624', 'abnormal circulating cysteine level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301816, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010209', 'abnormal circulating chemokine level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301817, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012326', 'increased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301818, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301819, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301820, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008805', 'decreased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301821, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301822, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301823, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0013255', 'abnormal circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301824, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010215', 'abnormal circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301825, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301826, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301827, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031065', 'increased circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301828, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301829, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012327', 'abnormal circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301830, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011889', 'abnormal circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301831, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012619', 'increased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301832, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005311', 'abnormal circulating amino acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301833, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301834, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301835, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301836, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301837, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301838, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301839, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0000188', 'abnormal circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(301840, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012331', 'increased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301841, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020257', 'increased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301842, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301843, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301844, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0002965', 'increased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301845, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301846, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0030757', 'abnormal circulating histamine level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301847, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0013403', 'abnormal circulating lactate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(301848, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301849, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011888', 'abnormal circulating total protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301850, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301851, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012329', 'increased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301852, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301853, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301854, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012325', 'decreased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301855, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020256', 'abnormal circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301856, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012616', 'increased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301857, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008804', 'abnormal circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301858, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020247', 'increased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301859, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0004730', 'abnormal circulating gastrin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301860, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301861, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301862, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301863, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031108', 'increased circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301864, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301865, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020217', 'increased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301866, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301867, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301868, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301869, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005308', 'abnormal circulating ammonia level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301870, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301871, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011885', 'abnormal circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301872, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031081', 'abnormal circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301873, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0001560', 'abnormal circulating insulin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301874, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031078', 'increased circulating troponin T level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301875, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0003349', 'abnormal circulating renin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301876, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010090', 'increased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301877, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0005419', 'decreased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301878, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301879, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010210', 'abnormal circulating cytokine level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301880, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020258', 'decreased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301881, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301882, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020248', 'decreased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301883, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301884, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012617', 'abnormal circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301885, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301886, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031076', 'decreased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301887, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301888, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012222', 'decreased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301889, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301890, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0020246', 'abnormal circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301891, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0008806', 'increased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301892, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(301893, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0012333', 'increased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301894, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301895, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301896, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0011886', 'increased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301897, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301898, 'HP:0012509', 'Reduced thyroxin-binding globulin', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(301899, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0001191', 'abnormal skin condition', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301900, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0009931', 'abnormal skin appearance', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301901, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0003941', 'abnormal skin development', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301902, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0009563', 'dyskeratosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301903, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0002060', 'abnormal skin morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301904, 'HP:0100579', 'Mucosal telangiectasiae', 'MP:0011239', 'abnormal skin coloration', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(301905, 'HP:0031201', 'Granular casts', 'MP:0002893', 'ketoaciduria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301906, 'HP:0031201', 'Granular casts', 'MP:0010107', 'abnormal renal reabsorption', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301907, 'HP:0031201', 'Granular casts', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301908, 'HP:0031201', 'Granular casts', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301909, 'HP:0031201', 'Granular casts', 'MP:0031481', 'decreased urine xanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301910, 'HP:0031201', 'Granular casts', 'MP:0011420', 'pyuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301911, 'HP:0031201', 'Granular casts', 'MP:0002987', 'abnormal urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301912, 'HP:0031201', 'Granular casts', 'MP:0011467', 'decreased urine urea nitrogen level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301913, 'HP:0031201', 'Granular casts', 'MP:0011444', 'abnormal renal water homeostasis', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301914, 'HP:0031201', 'Granular casts', 'MP:0031483', 'decreased urine hypoxanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301915, 'HP:0031201', 'Granular casts', 'MP:0003621', 'dysuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301916, 'HP:0031201', 'Granular casts', 'MP:0011758', 'renal ischemia', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301917, 'HP:0031201', 'Granular casts', 'MP:0001948', 'vesicoureteral reflux', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301918, 'HP:0031201', 'Granular casts', 'MP:0002988', 'decreased urine osmolality', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301919, 'HP:0031201', 'Granular casts', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301920, 'HP:0031201', 'Granular casts', 'MP:0006273', 'abnormal urine organic cation level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301921, 'HP:0031201', 'Granular casts', 'MP:0009350', 'decreased urine pH', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301922, 'HP:0031201', 'Granular casts', 'MP:0011923', 'abnormal bladder urine volume', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301923, 'HP:0031201', 'Granular casts', 'MP:0013305', 'isosthenuria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301924, 'HP:0031201', 'Granular casts', 'MP:0009348', 'abnormal urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301925, 'HP:0031201', 'Granular casts', 'MP:0009349', 'increased urine pH', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301926, 'HP:0031201', 'Granular casts', 'MP:0003589', 'abnormal ureter physiology', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301927, 'HP:0031201', 'Granular casts', 'MP:0011466', 'increased urine urea nitrogen level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301928, 'HP:0031201', 'Granular casts', 'MP:0013285', 'abnormal renal filtration', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301929, 'HP:0031201', 'Granular casts', 'MP:0011900', 'podocyturia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301930, 'HP:0031201', 'Granular casts', 'MP:0011432', 'decreased urine flow rate', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301931, 'HP:0031201', 'Granular casts', 'MP:0011431', 'increased urine flow rate', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301932, 'HP:0031201', 'Granular casts', 'MP:0011421', 'cylindruria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301933, 'HP:0031201', 'Granular casts', 'MP:0008055', 'increased urine osmolality', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301934, 'HP:0031201', 'Granular casts', 'MP:0011418', 'leukocyturia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301935, 'HP:0031201', 'Granular casts', 'MP:0001761', 'abnormal urination pattern', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301936, 'HP:0031201', 'Granular casts', 'MP:0031479', 'increased urine xanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301937, 'HP:0031201', 'Granular casts', 'MP:0009645', 'crystalluria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301938, 'HP:0031201', 'Granular casts', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301939, 'HP:0031201', 'Granular casts', 'MP:0031484', 'increased urine hypoxanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301940, 'HP:0031201', 'Granular casts', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301941, 'HP:0031201', 'Granular casts', 'MP:0014037', 'stranguria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301942, 'HP:0031201', 'Granular casts', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301943, 'HP:0031201', 'Granular casts', 'MP:0002136', 'abnormal kidney physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301944, 'HP:0031201', 'Granular casts', 'MP:0031480', 'abnormal urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301945, 'HP:0031201', 'Granular casts', 'MP:0009643', 'abnormal urine homeostasis', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301946, 'HP:0031201', 'Granular casts', 'MP:0000327', 'hemosiderinuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301947, 'HP:0031201', 'Granular casts', 'MP:0001756', 'abnormal urination', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301948, 'HP:0031201', 'Granular casts', 'MP:0003280', 'urinary incontinence', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301949, 'HP:0031201', 'Granular casts', 'MP:0011417', 'abnormal renal transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301950, 'HP:0031201', 'Granular casts', 'MP:0030619', 'homogentisic aciduria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301951, 'HP:0031201', 'Granular casts', 'MP:0010028', 'aciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(301952, 'HP:0010976', 'B lymphocytopenia', 'MP:0008083', 'decreased single-positive T cell number', 0.41935483870967744, 10.66072830811612, 2.1143859629163564, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301953, 'HP:0010976', 'B lymphocytopenia', 'MP:0013683', 'decreased early germinal center B cell number', 0.4215686274509804, 12.285219173023913, 2.275755475596216, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301954, 'HP:0010976', 'B lymphocytopenia', 'MP:0013685', 'decreased late germinal center B cell number', 0.4215686274509804, 12.285219173023913, 2.275755475596216, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301955, 'HP:0010976', 'B lymphocytopenia', 'MP:0013672', 'decreased mature NK cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301956, 'HP:0010976', 'B lymphocytopenia', 'MP:0008170', 'decreased B-1b cell number', 0.40384615384615385, 12.285219173023913, 2.227406229717142, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301957, 'HP:0010976', 'B lymphocytopenia', 'MP:0012768', 'decreased KLRG1-positive NK cell number', 0.42857142857142855, 10.66072830811612, 2.13749469253638, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301958, 'HP:0010976', 'B lymphocytopenia', 'MP:0013420', 'decreased CD5-positive gamma-delta T cell number', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301959, 'HP:0010976', 'B lymphocytopenia', 'MP:0008209', 'decreased pre-B cell number', 0.47191011235955055, 12.285219173023913, 2.4078038043626853, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301960, 'HP:0010976', 'B lymphocytopenia', 'MP:0013768', 'decreased marginal zone precursor B cell number', 0.46153846153846156, 12.285219173023913, 2.381197420790697, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301961, 'HP:0010976', 'B lymphocytopenia', 'MP:0013426', 'decreased memory-marker NK cell number', 0.42857142857142855, 10.66072830811612, 2.13749469253638, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301962, 'HP:0010976', 'B lymphocytopenia', 'MP:0008168', 'decreased B-1a cell number', 0.40384615384615385, 12.285219173023913, 2.227406229717142, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301963, 'HP:0010976', 'B lymphocytopenia', 'MP:0008050', 'decreased memory T cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301964, 'HP:0010976', 'B lymphocytopenia', 'MP:0012361', 'decreased large unstained cell number', 0.4588235294117647, 10.66072830811612, 2.2116493818934657, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301965, 'HP:0010976', 'B lymphocytopenia', 'MP:0005017', 'decreased B cell number', 0.4883720930232558, 12.285219173023913, 2.4494403852266173, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301966, 'HP:0010976', 'B lymphocytopenia', 'MP:0008098', 'decreased plasma cell number', 0.4375, 12.285219173023913, 2.3183579077006127, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301967, 'HP:0010976', 'B lymphocytopenia', 'MP:0000726', 'absent lymphocyte', 0.43820224719101125, 10.66072830811612, 2.1613780560811917, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301968, 'HP:0010976', 'B lymphocytopenia', 'MP:0013276', 'absent alpha-beta T cells', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301969, 'HP:0010976', 'B lymphocytopenia', 'MP:0008174', 'decreased follicular B cell number', 0.4117647058823529, 12.285219173023913, 2.249137536808373, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301970, 'HP:0010976', 'B lymphocytopenia', 'MP:0005016', 'decreased lymphocyte cell number', 0.46987951807228917, 10.66072830811612, 2.238137144975082, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301971, 'HP:0010976', 'B lymphocytopenia', 'MP:0008071', 'absent B cells', 0.44680851063829785, 12.285219173023913, 2.3428914788277915, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301972, 'HP:0010976', 'B lymphocytopenia', 'MP:0013675', 'decreased Ly6C-positive mature NK cell number', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301973, 'HP:0010976', 'B lymphocytopenia', 'MP:0008185', 'decreased naive B cell number', 0.42857142857142855, 12.285219173023913, 2.2945792492951647, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301974, 'HP:0010976', 'B lymphocytopenia', 'MP:0004978', 'decreased B-1 B cell number', 0.42, 12.285219173023913, 2.271517566005168, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301975, 'HP:0010976', 'B lymphocytopenia', 'MP:0013417', 'decreased memory-marker gamma-delta T cell number', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301976, 'HP:0010976', 'B lymphocytopenia', 'MP:0013666', 'decreased immature NK cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301977, 'HP:0010976', 'B lymphocytopenia', 'MP:0008100', 'absent plasma cells', 0.40384615384615385, 12.285219173023913, 2.227406229717142, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301978, 'HP:0010976', 'B lymphocytopenia', 'MP:0008178', 'decreased germinal center B cell number', 0.43, 12.285219173023913, 2.298400366428852, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301979, 'HP:0010976', 'B lymphocytopenia', 'MP:0000221', 'decreased leukocyte cell number', 0.4177215189873418, 10.255471829629862, 2.0697659941657363, 'UPHENO:0085330', 'abnormally decreased number of leukocyte'),
(301980, 'HP:0010976', 'B lymphocytopenia', 'MP:0008070', 'absent T cells', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301981, 'HP:0010976', 'B lymphocytopenia', 'MP:0008347', 'decreased gamma-delta T cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301982, 'HP:0010976', 'B lymphocytopenia', 'MP:0012765', 'decreased alpha-beta T cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301983, 'HP:0010976', 'B lymphocytopenia', 'MP:0008045', 'decreased NK cell number', 0.43820224719101125, 10.66072830811612, 2.1613780560811917, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301984, 'HP:0010976', 'B lymphocytopenia', 'MP:0008212', 'absent mature B cells', 0.42, 12.285219173023913, 2.271517566005168, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301985, 'HP:0010976', 'B lymphocytopenia', 'MP:0008729', 'decreased memory B cell number', 0.42, 12.285219173023913, 2.271517566005168, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301986, 'HP:0010976', 'B lymphocytopenia', 'MP:0008207', 'decreased B-2 B cell number', 0.42857142857142855, 12.285219173023913, 2.2945792492951647, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301987, 'HP:0010976', 'B lymphocytopenia', 'MP:0013669', 'decreased Ly6C-positive immature NK cell number', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301988, 'HP:0010976', 'B lymphocytopenia', 'MP:0005018', 'decreased T cell number', 0.43820224719101125, 10.66072830811612, 2.1613780560811917, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301989, 'HP:0010976', 'B lymphocytopenia', 'MP:0004974', 'decreased regulatory T cell number', 0.4105263157894737, 10.66072830811612, 2.092010878548068, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301990, 'HP:0010976', 'B lymphocytopenia', 'MP:0000238', 'absent pre-B cells', 0.42, 12.285219173023913, 2.271517566005168, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301991, 'HP:0010976', 'B lymphocytopenia', 'MP:0008211', 'decreased mature B cell number', 0.4666666666666667, 12.285219173023913, 2.3943897512193986, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(301992, 'HP:0010976', 'B lymphocytopenia', 'MP:0013423', 'decreased KLRG1-positive gamma-delta T cell number', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(301993, 'HP:0000830', 'Anterior hypopituitarism', 'MP:0003348', 'hypopituitarism', 0.4024390243902439, 14.491670050491338, 2.414956222564925, 'UPHENO:0077890', 'decreased secretion in pituitary gland'),
(301994, 'HP:0000260', 'Wide anterior fontanel', 'MP:0000085', 'large anterior fontanelle', 0.46987951807228917, 16.19210976863243, 2.758322086823548, 'UPHENO:0001328', 'increased size of the anterior fontanel'),
(301995, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030387', 'large posterior fontanelle', 0.4235294117647059, 14.732678149995134, 2.4979436564074406, 'UPHENO:0001192', 'increased size of the fontanelle'),
(301996, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030388', 'large fontanelles', 0.4444444444444444, 14.732678149995134, 2.558878065784572, 'UPHENO:0001192', 'increased size of the fontanelle'),
(301997, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030029', 'wide cranial sutures', 0.44871794871794873, 14.384754846574829, 2.540609707838972, 'UPHENO:0006166', 'increased width of cranial suture'),
(301998, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030353', 'wide sagittal suture', 0.42857142857142855, 14.384754846574829, 2.4829206459825404, 'UPHENO:0006166', 'increased width of cranial suture'),
(301999, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030431', 'wide metopic suture', 0.42168674698795183, 14.384754846574829, 2.4628967654920726, 'UPHENO:0006166', 'increased width of cranial suture'),
(302000, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030357', 'wide lambdoid suture', 0.42857142857142855, 14.384754846574829, 2.4829206459825404, 'UPHENO:0006166', 'increased width of cranial suture'),
(302001, 'HP:0000260', 'Wide anterior fontanel', 'MP:0030351', 'wide coronal suture', 0.42857142857142855, 14.384754846574829, 2.4829206459825404, 'UPHENO:0006166', 'increased width of cranial suture'),
(302002, 'HP:0002751', 'Kyphoscoliosis', 'MP:0006322', 'abnormal perichondrium morphology', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(302003, 'HP:0002751', 'Kyphoscoliosis', 'MP:0004610', 'small vertebrae', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(302004, 'HP:0002751', 'Kyphoscoliosis', 'MP:0013844', 'abnormal perichondrial ossification', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(302005, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004969', 'pale kidney', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302006, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011402', 'renal cast', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302007, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302008, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003881', 'abnormal nephron morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302009, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302010, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0012024', 'abnormal nephron morphogenesis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302011, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002135', 'abnormal kidney morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302012, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(302013, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002956', 'decreased compensatory renal growth', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302014, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302015, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302016, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302017, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011534', 'granular kidney', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302018, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0009641', 'kidney degeneration', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302019, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0000521', 'abnormal kidney cortex morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302020, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011381', 'abnormal kidney lobe morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302021, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002703', 'abnormal renal tubule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302022, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302023, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302024, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302025, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003600', 'ectopic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302026, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302027, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004195', 'abnormal kidney calyx morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302028, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0009860', 'nephrosclerosis', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302029, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302030, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003197', 'nephrocalcinosis', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302031, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302032, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003014', 'abnormal kidney medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302033, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011364', 'abnormal metanephros morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302034, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302035, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0000534', 'abnormal ureter morphology', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(302036, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302037, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002955', 'increased compensatory renal growth', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302038, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0008528', 'polycystic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302039, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0012026', 'abnormal S-shaped body morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302040, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302041, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003985', 'renal fibrosis', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302042, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0002706', 'abnormal kidney size', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302043, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0008487', 'abnormal mesonephros morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302044, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003613', 'abnormal kidney medulla development', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302045, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0003675', 'kidney cyst', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302046, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011383', 'abnormal kidney capsule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302047, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0000527', 'abnormal kidney development', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302048, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0012025', 'abnormal comma shaped body morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302049, 'HP:0032591', 'Renal interstitial hemosiderin', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(302050, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302051, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302052, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302053, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302054, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302055, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302056, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302057, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302058, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302059, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302060, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302061, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302062, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302063, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302064, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302065, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302066, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302067, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302068, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302069, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302070, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302071, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302072, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302073, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302074, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302075, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302076, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302077, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302078, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302079, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302080, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302081, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302082, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302083, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302084, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302085, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302086, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302087, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302088, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302089, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302090, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302091, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302092, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302093, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302094, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302095, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302096, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302097, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302098, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302099, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302100, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302101, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302102, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302103, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302104, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302105, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302106, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302107, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302108, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302109, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302110, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302111, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302112, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302113, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302114, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302115, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302116, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302117, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302118, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302119, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302120, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302121, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302122, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302123, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302124, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302125, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302126, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302127, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302128, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302129, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302130, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302131, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302132, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302133, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302134, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302135, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302136, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302137, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302138, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302139, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302140, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302141, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302142, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302143, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302144, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302145, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302146, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302147, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302148, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302149, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302150, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302151, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302152, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302153, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302154, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302155, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302156, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302157, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302158, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302159, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302160, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302161, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302162, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302163, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302164, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302165, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302166, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302167, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302168, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302169, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302170, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302171, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302172, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302173, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302174, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302175, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302176, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302177, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302178, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302179, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302180, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302181, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302182, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302183, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302184, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302185, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302186, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302187, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302188, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302189, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302190, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302191, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302192, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302193, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302194, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302195, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302196, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302197, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302198, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302199, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302200, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302201, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302202, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302203, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302204, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302205, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302206, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302207, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302208, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302209, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302210, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302211, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302212, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302213, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302214, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302215, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302216, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302217, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302218, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302219, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302220, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302221, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302222, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302223, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302224, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302225, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302226, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302227, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302228, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302229, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302230, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302231, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302232, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302233, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302234, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302235, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302236, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302237, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302238, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302239, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302240, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302241, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302242, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302243, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302244, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302245, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302246, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302247, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302248, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302249, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302250, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302251, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302252, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302253, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302254, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302255, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302256, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302257, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302258, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302259, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302260, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302261, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302262, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302263, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302264, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302265, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302266, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302267, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302268, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302269, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302270, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302271, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302272, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302273, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302274, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302275, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302276, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302277, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302278, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302279, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302280, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302281, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302282, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302283, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302284, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302285, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302286, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302287, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302288, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302289, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302290, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302291, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302292, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302293, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302294, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302295, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302296, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302297, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302298, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302299, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302300, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302301, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302302, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302303, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302304, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302305, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302306, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302307, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302308, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302309, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302310, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302311, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302312, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302313, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302314, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302315, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302316, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302317, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302318, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302319, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302320, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302321, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302322, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302323, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302324, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302325, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302326, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302327, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302328, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302329, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302330, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302331, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302332, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302333, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302334, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302335, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302336, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302337, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302338, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302339, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302340, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302341, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302342, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302343, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302344, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302345, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302346, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302347, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302348, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302349, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302350, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302351, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302352, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302353, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302354, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302355, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302356, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302357, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302358, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302359, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302360, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302361, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302362, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302363, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302364, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302365, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302366, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302367, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302368, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302369, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302370, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302371, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302372, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302373, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302374, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302375, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302376, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302377, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302378, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302379, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302380, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302381, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302382, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302383, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302384, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302385, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302386, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302387, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302388, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302389, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302390, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302391, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302392, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302393, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302394, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302395, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302396, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302397, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302398, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302399, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302400, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302401, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302402, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302403, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302404, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302405, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302406, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302407, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302408, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302409, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302410, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302411, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302412, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302413, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302414, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302415, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302416, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302417, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302418, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302419, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302420, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302421, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302422, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302423, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302424, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302425, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302426, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302427, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302428, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302429, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302430, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302431, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302432, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302433, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302434, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302435, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302436, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302437, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302438, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302439, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302440, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302441, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302442, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302443, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302444, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302445, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302446, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302447, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302448, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302449, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302450, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302451, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302452, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302453, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302454, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302455, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302456, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302457, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302458, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302459, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302460, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302461, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302462, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302463, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302464, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302465, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302466, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302467, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302468, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302469, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302470, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302471, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302472, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302473, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302474, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302475, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302476, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302477, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302478, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302479, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302480, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302481, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302482, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302483, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302484, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302485, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302486, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302487, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302488, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302489, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302490, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302491, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302492, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302493, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302494, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302495, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302496, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302497, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302498, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302499, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302500, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302501, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302502, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302503, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302504, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302505, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302506, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302507, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302508, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302509, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302510, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302511, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302512, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302513, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302514, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302515, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302516, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302517, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302518, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302519, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302520, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302521, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302522, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302523, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302524, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302525, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302526, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302527, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302528, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302529, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302530, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302531, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302532, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302533, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302534, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302535, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302536, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302537, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302538, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302539, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302540, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302541, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302542, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302543, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302544, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302545, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302546, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302547, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302548, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302549, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302550, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302551, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302552, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302553, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302554, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302555, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302556, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302557, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302558, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302559, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302560, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302561, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302562, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302563, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302564, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302565, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302566, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302567, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302568, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302569, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302570, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302571, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302572, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302573, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302574, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302575, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302576, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302577, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302578, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302579, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302580, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302581, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302582, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302583, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302584, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302585, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302586, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302587, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302588, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302589, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302590, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302591, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302592, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302593, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302594, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302595, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302596, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302597, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302598, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302599, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302600, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302601, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302602, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302603, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302604, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302605, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302606, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302607, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302608, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302609, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302610, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302611, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302612, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302613, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302614, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302615, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302616, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302617, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302618, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302619, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302620, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302621, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302622, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302623, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302624, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302625, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302626, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302627, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302628, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302629, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302630, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302631, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302632, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302633, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302634, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302635, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302636, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302637, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302638, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302639, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302640, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302641, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302642, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302643, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302644, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302645, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302646, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302647, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302648, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302649, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302650, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302651, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302652, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302653, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302654, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302655, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302656, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302657, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302658, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302659, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302660, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302661, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302662, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302663, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302664, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302665, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302666, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302667, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302668, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302669, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302670, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302671, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302672, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302673, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302674, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302675, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302676, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302677, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302678, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302679, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302680, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302681, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302682, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302683, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302684, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302685, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302686, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302687, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302688, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302689, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302690, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302691, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302692, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302693, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302694, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302695, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302696, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302697, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302698, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302699, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302700, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302701, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302702, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302703, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302704, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302705, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302706, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302707, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302708, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302709, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302710, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302711, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302712, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302713, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302714, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302715, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302716, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302717, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302718, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302719, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302720, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302721, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302722, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302723, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302724, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302725, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302726, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302727, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302728, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302729, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302730, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302731, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302732, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302733, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302734, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302735, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302736, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302737, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302738, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302739, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302740, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302741, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302742, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302743, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302744, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302745, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302746, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302747, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302748, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302749, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302750, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302751, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302752, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302753, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302754, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302755, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302756, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302757, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302758, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302759, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302760, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302761, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302762, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302763, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302764, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302765, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302766, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302767, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302768, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302769, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302770, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302771, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302772, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302773, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302774, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302775, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302776, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302777, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302778, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302779, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302780, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302781, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302782, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302783, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302784, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302785, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302786, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302787, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302788, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302789, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302790, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302791, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(302792, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302793, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302794, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302795, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302796, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302797, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302798, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302799, 'HP:5000021', 'Anti-Ma antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302800, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.425, 7.8051695233081215, 1.8213173933738052, 'UPHENO:0076730', 'abnormal ear morphology'),
(302801, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0002102', 'abnormal ear morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(302802, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0012176', 'abnormal head development', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(302803, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0020290', 'floppy ears', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(302804, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0000026', 'abnormal inner ear morphology', 0.4594594594594595, 7.8051695233081215, 1.8937156518782319, 'UPHENO:0076730', 'abnormal ear morphology'),
(302805, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0011238', 'abnormal inner ear development', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(302806, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0006287', 'inner ear cyst', 0.40476190476190477, 7.8051695233081215, 1.7774237770559287, 'UPHENO:0076730', 'abnormal ear morphology'),
(302807, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0002729', 'abnormal inner ear canal morphology', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(302808, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0000020', 'scaly ears', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(302809, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0030226', 'middle ear polyps', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(302810, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0030161', 'absent auditory bulla', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(302811, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0003938', 'abnormal ear development', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(302812, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0003737', 'ossification of pinnae', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(302813, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0004426', 'abnormal cochlear labyrinth morphology', 0.40476190476190477, 7.8051695233081215, 1.7774237770559287, 'UPHENO:0076730', 'abnormal ear morphology'),
(302814, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0002859', 'abnormal inner ear canal fusion', 0.425, 7.8051695233081215, 1.8213173933738052, 'UPHENO:0076730', 'abnormal ear morphology'),
(302815, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0000049', 'abnormal middle ear morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(302816, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0030160', 'abnormal auditory bulla morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(302817, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0004427', 'abnormal vestibular labyrinth morphology', 0.40476190476190477, 7.8051695233081215, 1.7774237770559287, 'UPHENO:0076730', 'abnormal ear morphology'),
(302818, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0002177', 'abnormal outer ear morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(302819, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(302820, 'HP:0040096', 'Neoplasm of the inner ear', 'MP:0000432', 'abnormal head morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(302821, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302822, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014207', 'increased intestinal epithelial chloride transmembrane transport', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302823, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005036', 'diarrhea', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302824, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302825, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008004', 'abnormal stomach pH', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302826, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302827, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302828, 'HP:0030145', 'Lack of bowel sounds', 'MP:0013757', 'decreased intestinal phytosterol absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302829, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302830, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001663', 'abnormal digestive system physiology', 0.5384615384615384, 9.977790647831666, 2.3178991571417833, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302831, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302832, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302833, 'HP:0030145', 'Lack of bowel sounds', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302834, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302835, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302836, 'HP:0030145', 'Lack of bowel sounds', 'MP:0006003', 'abnormal large intestinal transit time', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302837, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302838, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003292', 'melena', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302839, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302840, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005037', 'mucous diarrhea', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302841, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302842, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002645', 'abnormal intestinal cholesterol absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302843, 'HP:0030145', 'Lack of bowel sounds', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302844, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003291', 'interstinal hyperperistalsis', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302845, 'HP:0030145', 'Lack of bowel sounds', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302846, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302847, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302848, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302849, 'HP:0030145', 'Lack of bowel sounds', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302850, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001665', 'chronic diarrhea', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302851, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014203', 'abnormal intestinal epithelial chloride transmembrane transport', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302852, 'HP:0030145', 'Lack of bowel sounds', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302853, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302854, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003868', 'abnormal feces composition', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302855, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302856, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302857, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004773', 'abnormal bile composition', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(302858, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302859, 'HP:0030145', 'Lack of bowel sounds', 'MP:0000505', 'decreased digestive secretion', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302860, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302861, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003866', 'abnormal defecation', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302862, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302863, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014205', 'increased intestinal epithelial sodium ion transmembrane transport', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302864, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302865, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004108', 'abnormal esophageal peristalsis', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302866, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302867, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008006', 'increased stomach pH', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302868, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008003', 'achlorhydria', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302869, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003259', 'nausea', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302870, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302871, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302872, 'HP:0030145', 'Lack of bowel sounds', 'MP:0010155', 'abnormal intestine physiology', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302873, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302874, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48148148148148145, 5.110459900932426, 1.5686273630638505, 'UPHENO:0002833', 'abnormal digestive system'),
(302875, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302876, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302877, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002646', 'increased intestinal cholesterol absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302878, 'HP:0030145', 'Lack of bowel sounds', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302879, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302880, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302881, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302882, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302883, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008005', 'decreased stomach pH', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302884, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003256', 'biliary cirrhosis', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(302885, 'HP:0030145', 'Lack of bowel sounds', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302886, 'HP:0030145', 'Lack of bowel sounds', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302887, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302888, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302889, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001666', 'abnormal intestinal absorption', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302890, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302891, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302892, 'HP:0030145', 'Lack of bowel sounds', 'MP:0011220', 'increased intestinal calcium absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302893, 'HP:0030145', 'Lack of bowel sounds', 'MP:0011082', 'abnormal gastrointestinal motility', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302894, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302895, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302896, 'HP:0030145', 'Lack of bowel sounds', 'MP:0013755', 'abnormal intestinal phytosterol absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302897, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302898, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002647', 'decreased intestinal cholesterol absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302899, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302900, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302901, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302902, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005085', 'abnormal gallbladder physiology', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(302903, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014208', 'decreased intestinal epithelial chloride transmembrane transport', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302904, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302905, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003260', 'vomiting', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302906, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302907, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014202', 'abnormal intestinal epithelial transmembrane transport', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302908, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302909, 'HP:0030145', 'Lack of bowel sounds', 'MP:0006001', 'abnormal intestinal transit time', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302910, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302911, 'HP:0030145', 'Lack of bowel sounds', 'MP:0020147', 'abnormal defecation amount', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302912, 'HP:0030145', 'Lack of bowel sounds', 'MP:0010154', 'abnormal gastroesophageal sphincter physiology', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302913, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302914, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302915, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302916, 'HP:0030145', 'Lack of bowel sounds', 'MP:0009247', 'meteorism', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302917, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302918, 'HP:0030145', 'Lack of bowel sounds', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302919, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302920, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302921, 'HP:0030145', 'Lack of bowel sounds', 'MP:0014206', 'decreased intestinal epithelial sodium ion transmembrane transport', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302922, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003261', 'hematemesis', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302923, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003286', 'gastroesophageal reflux', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302924, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302925, 'HP:0030145', 'Lack of bowel sounds', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302926, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003252', 'abnormal bile duct physiology', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(302927, 'HP:0030145', 'Lack of bowel sounds', 'MP:0003746', 'stomatitis', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302928, 'HP:0030145', 'Lack of bowel sounds', 'MP:0000501', 'abnormal digestive secretion', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302929, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302930, 'HP:0030145', 'Lack of bowel sounds', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302931, 'HP:0030145', 'Lack of bowel sounds', 'MP:0006002', 'abnormal small intestinal transit time', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302932, 'HP:0030145', 'Lack of bowel sounds', 'MP:0005342', 'abnormal intestinal lipid absorption', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302933, 'HP:0030145', 'Lack of bowel sounds', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302934, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302935, 'HP:0030145', 'Lack of bowel sounds', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302936, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008002', 'hyperchlorhydria', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302937, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302938, 'HP:0030145', 'Lack of bowel sounds', 'MP:0011221', 'decreased intestinal calcium absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302939, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302940, 'HP:0030145', 'Lack of bowel sounds', 'MP:0010994', 'aerophagia', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(302941, 'HP:0030145', 'Lack of bowel sounds', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302942, 'HP:0030145', 'Lack of bowel sounds', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(302943, 'HP:0030145', 'Lack of bowel sounds', 'MP:0008001', 'hypochlorhydria', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
